FDA approves r4 Vasculars apheresis catheter
The FDA has granted 510(k) clearance to r4 Vascular’s Pherocious apheresis catheter, which includes a power-injectable contrast media for contrast-enhanced CT imaging.
In addition, the Maple Grove, Minn.-based company said the apheresis catheter has the capabilities to perform intravenous infusions and blood sampling, and is available in two sizes, 12.5F and 10.5F.
According to r4 Vascular, the Pherocious apheresis catheter is the fourth catheter in addition to the Pegasus, Zeus and DrainEx catheters, to be released by the company this year.
In addition, the Maple Grove, Minn.-based company said the apheresis catheter has the capabilities to perform intravenous infusions and blood sampling, and is available in two sizes, 12.5F and 10.5F.
According to r4 Vascular, the Pherocious apheresis catheter is the fourth catheter in addition to the Pegasus, Zeus and DrainEx catheters, to be released by the company this year.